Cargando…

Impact of gender and mutational differences in hormone receptor expressing non-small cell lung cancer

BACKGROUND: The incidence of lung cancer in the US has been decreasing but a bigger decline has been observed in men despite similar declines in tobacco use between men and women. Multiple theories have been proposed, including exposure to exogenous estrogens. Our study seeks to understand the relat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsu, Robert, Chen, Denaly, Xia, Bing, Feldman, Rebecca, Cozen, Wendy, Raez, Luis E., Borghaei, Hossein, Kim, Chul, Nagasaka, Misako, Mamdani, Hirva, Vanderwalde, Ari M., Lopes, Gilberto, Socinski, Mark A., Wozniak, Antoinette J., Spira, Alexander I., Liu, Stephen V., Nieva, Jorge J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494442/ https://www.ncbi.nlm.nih.gov/pubmed/37700839 http://dx.doi.org/10.3389/fonc.2023.1215524

Ejemplares similares

Characterization of KRAS Mutation Subtypes in Non–small Cell Lung Cancer
por: Judd, Julia, et al.
Publicado: (2021)

Pan-tumor survey of ROS1 fusions detected by next-generation RNA and whole transcriptome sequencing
por: Nagasaka, Misako, et al.
Publicado: (2023)

Risk Factors Associated with a Second Primary Lung Cancer in Patients with an Initial Primary Lung Cancer
por: Fisher, Amanda, et al.
Publicado: (2021)

Molecular characterization of Kita-Kyushu lung cancer antigen (KK-LC-1) expressing carcinomas
por: Hsu, Robert, et al.
Publicado: (2021)

Pan-tumor survey of RET fusions as detected by next-generation RNA sequencing identified RET fusion positive colorectal carcinoma as a unique molecular subset
por: Nagasaka, Misako, et al.
Publicado: (2023)

Spotlight on the treatment of ALK-rearranged non-small-cell lung cancer
por: Mamdani, Hirva, et al.
Publicado: (2017)

Histone Deacetylase Inhibition in Non-small Cell Lung Cancer: Hype or Hope?
por: Mamdani, Hirva, et al.
Publicado: (2020)

Pomalidomide-Induced Pulmonary Toxicity in Multiple Myeloma
por: Modi, Dipenkumar, et al.
Publicado: (2015)

Non-small cell to small cell lung cancer on PD-1 inhibitors: two cases on potential histologic transformation
por: Abdallah, Nadine, et al.
Publicado: (2018)

Personalized Medicine in Oncology; a Special Issue of the Journal of Personalized Medicine
por: VanderWalde, Ari
Publicado: (2021)

Effect of prior therapy on tumor mutational burden in NSCLC
por: Jonna, Sushma, et al.
Publicado: (2021)

The Applicability of the Results in the Asian Population of ORIENT-11 to a Western Population According to the ICH-E5 Framework
por: Liu, Stephen V., et al.
Publicado: (2022)

Immunotherapy in Lung Cancer: Current Landscape and Future Directions
por: Mamdani, Hirva, et al.
Publicado: (2022)

Rational use of cetuximab in the treatment of advanced non-small cell lung cancer
por: Aggarwal, Charu, et al.
Publicado: (2009)

Personalized medicine and treatment approaches in non-small-cell lung carcinoma
por: Vadakara, Joseph, et al.
Publicado: (2012)

Treatment Paradigms for Advanced Non‐Small Cell Lung Cancer at Academic Medical Centers: Involvement in Clinical Trial Endpoint Design
por: Aggarwal, Charu, et al.
Publicado: (2017)

A retrospective study evaluating the pretreatment tumor volume (PTV) in non-small cell lung cancer (NSCLC) as a predictor of response to program death-1 (PD-1) inhibitors
por: Nagasaka, Misako, et al.
Publicado: (2019)

Comparison of Chemotherapy vs Chemotherapy Plus Total Hysterectomy for Women With Uterine Cancer With Distant Organ Metastasis
por: Wang, Yuefeng, et al.
Publicado: (2021)

Lung Cancer Disparities in Hispanics: Molecular Diagnosis and Use of Immunotherapy
por: Raez, Luis E., et al.
Publicado: (2020)

Inhibitor of the Nuclear Transport Protein XPO1 Enhances the Anticancer Efficacy of KRAS G12C Inhibitors in Preclinical Models of KRAS G12C–Mutant Cancers
por: Khan, Husain Yar, et al.
Publicado: (2022)

Microsatellite instability status determined by next‐generation sequencing and compared with PD‐L1 and tumor mutational burden in 11,348 patients
por: Vanderwalde, Ari, et al.
Publicado: (2018)

Precision Medicine in Oncology: A Review of Multi-Tumor Actionable Molecular Targets with an Emphasis on Non-Small Cell Lung Cancer
por: Stein, Matthew K., et al.
Publicado: (2021)

Role of novel cancer gene SLITRK3 to activate NTRK3 in squamous cell lung cancer
por: Bollig-Fischer, Aliccia, et al.
Publicado: (2021)

Editorial: The Role of Plant Hormones in Plant-Microbe Symbioses
por: Foo, Eloise, et al.
Publicado: (2019)

Phase 2 Trial of Nivolumab and Ramucirumab for Relapsed Mesothelioma: HCRN-LUN15-299
por: Dudek, Arkadiusz Z., et al.
Publicado: (2023)

Gender, sex hormones and pulmonary hypertension
por: Austin, Eric D., et al.
Publicado: (2013)

The GENDER ATTENTION Observational Study: Gender and Hormonal Status Differences in the Incidence of Adverse Events During Cyclosporine Treatment in Psoriatic Patients
por: Colombo, Delia, et al.
Publicado: (2017)

How to Treat EGFR-Mutated Non–Small Cell Lung Cancer
por: Belani, Neel, et al.
Publicado: (2023)

Spotlight on Sotorasib (AMG 510) for KRAS(G12C) Positive Non-Small Cell Lung Cancer
por: Zhang, Shannon S, et al.
Publicado: (2021)

Spotlight on Amivantamab (JNJ-61186372) for EGFR Exon 20 Insertions Positive Non-Small Cell Lung Cancer
por: Brazel, Danielle, et al.
Publicado: (2021)

Deconstructing ADAURA. It is Not Yet Time to Forgo Platinum-based Adjuvant Chemotherapy in Resected Early Stage (IB-IIIA) EGFR-mutant NSCLC
por: Brazel, Danielle, et al.
Publicado: (2022)

The development of amivantamab for the treatment of non-small cell lung cancer
por: Brazel, Danielle, et al.
Publicado: (2023)

Spotlight on Cemiplimab-rwlc in the Treatment of Non-Small Cell Lung Cancer (NSCLC): Focus on Patient Selection and Considerations
por: Ahn, Jeffrey, et al.
Publicado: (2023)

Penetrating the central nervous system sanctuary of KRAS, a target once thought “undruggable”
por: Nagasaka, Misako, et al.
Publicado: (2023)

Hormones and not gender influences outcome in severe infection
por: Angstwurm, M, et al.
Publicado: (2001)

Roles of Sex Hormones and Gender in the Gut Microbiota
por: Yoon, Kichul, et al.
Publicado: (2021)

CheckMate-722: The Rise and Fall of Nivolumab with Chemotherapy in TKI-Refractory EGFR-Mutant NSCLC
por: Lee, Alexandria T M, et al.
Publicado: (2023)

Establishment of a Molecular Tumor Board (MTB) and Uptake of Recommendations in a Community Setting
por: VanderWalde, Ari, et al.
Publicado: (2020)

Comparison of Carboplatin With Cisplatin in Small Cell Lung Cancer in US Veterans
por: Azar, Ibrahim, et al.
Publicado: (2022)

Large-scale characterization of gender differences in diagnosis prevalence and time to diagnosis
por: Sun, Tony Yue, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9vqib7adq6v0jr65iut6prsl7m